Introduction {#ss1}
============

Nationwide epidemiological surveys concerning idiopathic sudden sensorineural hearing loss (SSNHL) were conducted, using specific criteria \[[@CIT0001]\], four times by the Research Committees of the Ministry of Health and Welfare in Japan \[[@CIT0002]\]. The first, second, third, and fourth surveys were performed on patients who suffered from SSNHL and visited hospitals between July 1, 1971 and June 30, 1973; between January 1 and December 31, 1987; between January 1 and December 31, 1993; and between January 1 and December 31, 2001 \[[@CIT0002]\]. The criteria for SSNHL that have been used for nearly 40 years in Japan did not provide concrete figures for the hearing levels. In 2012, the Research Committee of the Ministry of Health and Welfare for Acute Profound Deafness established new criteria that defined hearing levels for SSNHL as 30 dB or more over three consecutive frequencies, in accordance with the definition widely used in other parts of the world ([Table I](#T1){ref-type="table"}) \[[@CIT0005]\].

###### 

Criteria for diagnosis of sudden deafness[^\*^](#T1_F1){ref-type="table-fn"}.

  ---------------------------------------------------------------------------------------
  Main symptoms
   Sudden onset
   Sensorineural hearing loss, usually severe
   Unknown etiology
  For reference
   Hearing loss (i.e. hearing loss of 30 dB or more over three consecutive frequencies)
    Sudden onset of hearing loss, but may progressively deteriorate over 72 h
    No history of recurrent episodes
    Unilateral hearing loss, but may be bilateral at the onset
   May be accompanied by tinnitus
   May be accompanied by vertigo, nausea, and/or vomiting, without recurrent episodes
   No cranial nerve symptoms other than from cranial nerve VIII
  Definite diagnosis: all of the above main symptoms are present
  ---------------------------------------------------------------------------------------

These criteria were established by the Research Committee of the Ministry of Health, Labour and Welfare in Japan in 2012.

Using the new criteria, the committee performed an epidemiological study of SSNHL on patients who visited hospitals or private ENT clinics during 1 year from April 1, 2012. This study presents the current status of SSNHL in Japan.

Material and methods {#ss2}
====================

Because we expected that many SSNHL patients visited only private ENT clinics, both hospitals and private clinics were included in this study, unlike previous surveys of hospitals only. To perform this study, Ehime, Aichi, and Iwate Prefectures were selected ([Figure 1](#F1){ref-type="fig"}). Ehime, Aichi, and Iwate Prefectures are located in the western, central, and northeastern regions of Japan, respectively. They contain the fourth largest city in Japan (Nagoya), provincial cities, and rural areas. Moreover, the incidence of SSNHL in each of these three prefectures was at the average level found in the 2001 national survey \[[@CIT0006]\].

![The three prefectures selected for the epidemiological study of sudden sensorineural hearing loss (SSNHL) in Japan.](OTO-134-1158-g001){#F1}

In April 2012, letters were mailed to all hospitals with ENT clinics and to private ENT clinics to inform them of the purpose of the survey with the new criteria for defining SSNHL. The subjects for this study were patients who suffered SSNHL between April 1, 2012 and March 31, 2013.

An intermediate survey was conducted in the autumn of 2012 to collect the number of patients and referrals from or to other hospitals or private clinics in Aichi. The final survey to collect the patient data was conducted in June or July 2013 in Ehime, Aichi, and Iwate, and it included date of birth, sex, date of onset of SSNHL, date of first clinic visit, and the presence or absence of referral from or to other hospitals or private clinics. Information regarding the patients' date of birth, sex, date of onset, and presence or absence of referral was used to identify duplicate patients. In case there was response only to the intermediate survey, and not to the final survey, we used the average monthly number of patients in the intermediate survey to estimate the annual number of patients in each hospital or clinic on the assumption of no seasonal difference. In the final survey, initial and final audiograms were requested for those patients whose birthday was the 3rd, 13th, or 23rd day of the month.

All data, including the hearing thresholds in the audiograms, were entered into a computer. From the audiogram data, the grade of the initial audiogram ([Table II](#T2){ref-type="table"}) \[[@CIT0007]\] and the recovery rate, defined by the Ministry of Health and Welfare in Japan ([Table III](#T3){ref-type="table"}) \[[@CIT0008]\], were obtained. From the audiograms, we also investigated the number of patients suffering acute low-tone sensorineural hearing loss (ALHL). In this study, we used criteria for ALHL described in the previous literature \[[@CIT0009]\].

###### 

Criteria for the grading of hearing loss in idiopathic sudden sensorineural hearing loss (SSNHL)[^\*^](#T2_F1){ref-type="table-fn"}.

  Grade   Criteria
  ------- --------------------
  1       PTA \<40 dB
  2       40 dB ≤PTA \<60 dB
  3       60 dB ≤PTA \<90 dB
  4       90 dB ≤PTA

This grading system was established by the Research Committee of the Ministry of Health and Welfare in Japan in 1988. This grading system is used for evaluation of the initial audiogram recorded for patients within 2 weeks after the onset. 'a' is appended for patients with vertigo, and 'b' is appended for patients without vertigo (e.g. grade 3a, grade 4b). PTA, arithmetic mean of the five frequencies; the five frequencies are 250, 500, 1000, 2000, and 4000 Hz.

###### 

Hearing improvement as defined by the Ministry of Health and Welfare in Japan\*.

  Status               Criteria
  -------------------- --------------------------------------------------------------------------------------------------------------------------------
  Complete recovery    All five frequencies of final audiograms are 20 dB or less, or improvement to the same degree of hearing in the unaffected ear
  Marked improvement   PTA improvement ≥30 dB
  Slight improvement   10 dB ≤PTA improvement \<30 dB
  No change            PTA improvement \<10 dB

PTA, arithmetic mean of the five frequencies; the five frequencies are 250, 500, 1000, 2000, and 4000 Hz.

\*These criteria were established in 1988.

The study protocol was approved by the Ethics Review Committees of Nagoya University, Iwate Medical University, and Ehime University. Statistical analyses were performed using Stata ver. 11.2 (Stata Corp., College Station, TX, USA) including 95% confidence interval (CI), Student's *t* tests, and chi-squared tests. Results were regarded as significant when *p* \< 0.05.

Results {#ss3}
=======

The response rate, number of patients, population, and incidence of SSNHL in each prefecture are shown in [Table IV](#T4){ref-type="table"}. In Iwate, all hospitals and private clinics responded; however, in Ehime and Aichi, not all hospitals and private clinics responded. The estimated number of patients was obtained by assuming that the number of patients was the same between hospitals that did and did not respond, taking into account hospital size, as shown in [Table IV](#T4){ref-type="table"}. In a similar manner, the estimated number of patients who visited only private clinics was also obtained. The actual number of patients reported to have visited hospitals was 265, 1249, and 149 in Ehime, Aichi, and Iwate, respectively. The actual number of patients who visited only private clinics was 614, 2044, and 432 in Ehime, Aichi, and Iwate, respectively. Of the total 4753 patients, 65.0% visited only private clinics. The female-to-male ratio was 1.22:1.00. It was estimated that the number of patients was 1019 (95% CI, 934--1105) in Ehime, 4582 (95% CI, 4257--4907) in Aichi, and 581 in Iwate. In total, it was estimated that 6182 (95% CI, 5847--6517) SSNHL patients visited hospitals or private clinics in 1 year in a population of 10 145 000; the incidence of SSNHL was 60.9 (95% CI, 57.6--64.2) per 100 000.

###### 

Results of the epidemiological survey in three prefectures in Japan.

  Source                                           Ehime               Aichi   Iwate                                                  
  ---------------------------- ------------------- ------------------- ------- ------- ----------- -------- -------- --------- ------ -------
  University hospitals         1 (1)               42.0                42.0    5 (5)   49.6        248.0    1 (1)    75.0      75.0   
  Other hospitals              400 beds or more    6 (6)               19.0    114.0   28 (31)     33.6\*   1041.9   2 (2)     21.5   43.0
                               200--399 beds       5 (6)               12.4    74.4    13 (18)     16.2\*   292.1    3 (3)     7.0    21.0
                               \< 200 beds         2 (3)               17.3†   52.0    10 (12)     6.0\*    72.0     2 (2)     5.0    10.0
  Private clinics                                  55 (66)             11.2    736.6   214 (307)   9.6\*    2931.8   34 (34)   12.7   432.0
  Population (thousand)        1415                                            7427                         1303                      
  Incidence/100 000 (95% CI)   72.0 (66.0--78.1)   61.7 (57.3--66.1)           44.6                                                   

Response rate: the numbers of hospitals and private clinics that responded are shown, with the numbers approached to participate in this study shown in parentheses. When patients were referred to hospitals from private clinics, they were calculated as being patients of hospitals. The number of patients from private clinics indicates that they visited only private clinics. The estimated number of patients was obtained by assuming that the number of patients was the same between hospitals that did and did not respond, taking into account the size of the hospital. The number of ENT outpatients was not significantly different between hospitals that did and did not respond in each size of hospital.

\*In Aichi, 9 hospitals and 67 private clinics only reported the number of patients who visited from April through October. The average number of patients was estimated by assuming no seasonal difference in these hospitals and clinics.

^†^Of 3 hospitals with less than 200 beds in Ehime, 1 specialist hospital, providing mainly ENT services, reported 42 patients. It was assumed that the number of patients in the ordinary hospital that did not respond was five, as for another ordinary hospital.

[Figure 2](#F2){ref-type="fig"} shows the incidence of SSNHL in each age group. The incidence increased from 9 per 100 000 for patients younger than 20 years to 94 per 100 000 for patients in the age range 60--69 years. The percentage of patients younger than 20 years was 3.2%. The youngest patient was aged 8 years and the oldest patient was aged 96 years. The average age was 54.2 years (SD = 17.1). There was a tendency for more females than males to be affected in the younger age groups.

![Distribution of annual incidence of sudden sensorineural hearing loss (SSNHL) for men and women, in each age group.](OTO-134-1158-g002){#F2}

The season of onset was divided into Japanese spring (March--May), summer (June--August), autumn (September--November), and winter (December--February). The number of patients reported in each season from the final survey was 966, 1094, 1103, and 936 in spring, summer, autumn, and winter, respectively. There were no significant differences between the four seasons.

In patients from whom initial and final audiograms were obtained, 98.2% of the patients had hearing loss of 30 dB or more over three consecutive frequencies on the initial audiograms. Because the recovery rate is significantly associated with the interval between the onset of SSNHL and the diagnosis, the recovery rate of patients who visited ENT doctors with hearing loss of 30 dB or more over three consecutive frequencies within 2 weeks after the onset of SSNHL in each grade was assessed ([Table V](#T5){ref-type="table"}). The presence or absence of vertigo was not considered because we did not obtain such information. The complete recovery rate was 67%, 37%, 32%, and 4%, for grades 1, 2, 3, and 4, respectively. When the final hearing level was graded, as shown in [Table II](#T2){ref-type="table"}, grade 2 patients who visited an ENT doctor within 2 weeks after the onset of SSNHL had a final hearing level of grade 1 in 75% of cases and grade 2 in 23% of cases. Those patients classified as grade 3 at the first visit had a final hearing level of grade 1, grade 2, and grade 3 in 45%, 26%, and 26% of cases, respectively. The patients with grade 4 at the first visit had a final hearing level of grade 1 in 21%, grade 2 in 4%, grade 3 in 46%, and grade 4 in 29% of cases.

###### 

Final hearing outcome in each grade of sudden sensorineural hearing loss (SSNHL).

  Grade   Complete recovery   Marked improvement   Slight improvement   No change   Total
  ------- ------------------- -------------------- -------------------- ----------- -------
  1       85                  0                    5                    36          126
  2       30                  5                    24                   22          81
  3       25                  23                   11                   20          79
  4       1                   9                    7                    7           24
  Total   141                 37                   47                   85          310

In patients whose initial audiograms had hearing loss of 30 dB or more over three consecutive frequencies, 23% of the patients had hearing loss corresponding to the criteria of ALHL. Definite and probable cases were 18% and 5%, respectively. There were 56 patients (42 female and 14 male) with definite ALHL and 16 patients (6 female and 10 male) with probable ALHL. In the definite group, the number of ALHL patients who were female was more than those who were male (*p* \< 0.01). The average age of the definite and probable ALHL patients was 43.0 years (SD = 14.7) and 63.7 years (SD = 9.0), respectively. The age of the definite ALHL patients was significantly younger than that of the patients with SSNHL (ALHL patients excluded) (*p* \< 0.01).

Discussion {#ss4}
==========

This study revealed that the annual incidence of SSNHL in Japan was 60.9 per 100 000 population. The incidence was much higher than rates reported previously in Japan \[[@CIT0002]\]. This difference may be because of the inclusion in the survey of private ENT clinics. The present survey revealed that 65% of SSNHL patients visited only private ENT clinics. The previous reports in Japan did not include patients who visited only private clinics \[[@CIT0002]\]. The present investigation included private clinics but selected only three prefectures in Japan. This was a limitation of the study. The incidence reported here was higher than the 27/100 000 reported from the United States \[[@CIT0012]\] but lower than the 160--300/100 000 reported from Germany \[[@CIT0013]\]. The incidence of SSNHL may be related to whether or not private clinics or outpatient (ambulatory) treatment are included. In Japan, the estimated annual number of patients with SSNHL increased over the years 1972 to 2001 \[[@CIT0004]\]. Because these earlier surveys were carried out using the old criteria, it is difficult to compare the previous and present surveys for investigation of trends in the incidence of SSNHL in Japan. This study revealed that the percentage of hearing loss corresponding to definite ALHL increased to 18% from 9% that was reported previously using the old criteria \[[@CIT0010]\]. However, it seems that the annual number of SSNHL patients who visited hospitals did not increase compared with investigations conducted 10 years ago. Wu et al. \[[@CIT0015]\] examined the incidence of SSNHL in Taiwan from the country's National Health Insurance program database, capturing inpatient medical claims for more than 20 million people. They found an annual incidence of 10.21 per 100 000 in 2002. The most suitable method for conducting such surveys may vary by country. In Japan, which has a population of 128 million, there are about 10 000 ENT doctors, and half of them own private clinics. Direct communication using questionnaires administered directly to ENT doctors working in both hospitals and private clinics may be a more useful method of investigating the incidence of SSNHL in Japan.

The incidence of SSNHL was 72.0, 61.7, and 44.6 per 100 000 in the prefectures of Ehime, Aichi, and Iwate, respectively. The area of Iwate is 2.69 times larger than that of Ehime and 2.96 times larger than that of Aichi. The number of ENT doctors in Iwate is the lowest per population among the three prefectures. The influence of the large earthquake that hit eastern Japan on March 11, 2011 still remains in Iwate. Such social factors may be associated with the low incidence of SSNHL found in Iwate. The percentage of grade 1 SSNHL was 40%, 34%, and 29% in Ehime, Aichi, and Iwate Prefectures, respectively. It is probable that many patients with mild symptoms did not consult doctors in Iwate.

The present study demonstrated that the incidence of SSNHL was high in the 50s, 60s, and 70s age groups in Japan. There was a tendency for the peak of the incidence to move to the older generation compared with that of previous surveys in Japan \[[@CIT0004]\]. Because aging of the Japanese society is proceeding quickly, the number of aged people will increase more in the future. In the younger generation, the number of females with SSNHL was more than that of males. This tendency was associated with the incidence of definite ALHL in young females. Alexander and Harris \[[@CIT0012]\] reported that men were more likely to be affected than women in patients older than 55 years. On the contrary, Klemm et al. \[[@CIT0014]\] described an overall female preponderance in Germany. Our study revealed that there were more female patients in the younger generation, including those with definite ALHL. Previous studies have reported that some patients with ALHL or SSNHL had evidence of endolymphatic hydrops on MRI \[[@CIT0009]\]; therefore, some cases of SSNHL may be associated with Ménière's disease.

Regarding the recovery of hearing after SSNHL, we used criteria determined by the Research Committee of the Ministry of Health and Welfare in Japan ([Table III](#T3){ref-type="table"}). The criteria, which are often described as Furuhashi's criteria in Western countries \[[@CIT0017]\], utilize both the final hearing level and the size of the hearing gain, as per Siegel's criteria \[[@CIT0019]\]. It was found that the proportion with marked recovery was greater for grade 3 patients than for grade 2 patients ([Table V](#T5){ref-type="table"}). This reversal phenomenon may depend on utilization of the size of the hearing gain in the criteria. In the present study, we also evaluated hearing outcome utilizing only the hearing levels. The final hearing grade was recorded for each grade identified from the initial audiogram. The distribution of the final hearing grade for each initial hearing grade indicated that the grading method is useful for the evaluation of hearing outcome after SSNHL. It was obvious that patients with grade 4 SSNHL, who accounted for 8% of the total SSNHL patients, had the worst hearing outcome. By analyzing hearing outcome in each grade of SSNHL, we found that the degree of hearing recovery found in the present study was not significantly different compared with previous studies undertaken 30 or 40 years ago in Japan \[[@CIT0020]\]. It does not seem that treatment methods for SSNHL changed much during this period in Japan \[[@CIT0011]\].

In conclusion, an epidemiological survey of SSNHL conducted among hospitals and private clinics in Japan revealed that the incidence of SSNHL was 60.9 per 100 000 population. The incidence was high in the 50s, 60s, and 70s age groups. There were more females than males in the younger generation. When hearing outcome was evaluated in each grade of SSNHL, there were no significant differences between the present and past results. To improve the results of treatment for SSNHL of various etiologies, elucidation of the mechanisms of SSNHL is required for development of the most effective treatment for each etiology.
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